Capecitabine (X) single-agent therapy in patients (pts) with locally advanced/metastatic cholangiocarcinoma

被引：0
|
作者：
Sew, O. Sea [1 ]
Sookprasert, A. [1 ]
Bhudhisawad, V. [1 ]
Kaewket, V. [1 ]
Pirojkul, C. [1 ]
机构：
[1] Khon Kaen Univ, Fac Med, Srinagarind Hosp, Khon Kaen, Thailand
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：53 / 54
页数：2
相关论文
共 50 条
  • [21] Capecitabine chemoradiation (X-RT) as neoadjuvant therapy for patients (pts) with locally advanced breast cancer (LABC) refractory to anthracyclines.
    Gaui, MF
    Amorim, G
    Arcuri, R
    Pereira, G
    Moreira, D
    Djahjah, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 52S - 52S
  • [22] Single-agent capecitabine: A reference treatment for taxane-pretreated metastatic breast cancer?
    Seidman, AD
    O'Shaughnessy, J
    Misset, JL
    [J]. ONCOLOGIST, 2002, 7 : 20 - 28
  • [23] SINGLE-AGENT THERAPY
    HARGER, JH
    [J]. OBSTETRICS AND GYNECOLOGY, 1983, 62 (01): : 134 - 134
  • [24] Correction to: Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma
    Ofer Margalit
    Shun Yu
    Einat Shacham-Shmueli
    Gal Strauss
    Yu-Xiao Yang
    Yaacov R. Lawrence
    Kim A. Reiss
    Talia Golan
    Naama Halpern
    Dan Aderka
    Bruce Giantonio
    Ronac Mamtani
    Ben Boursi
    [J]. Journal of Cancer Research and Clinical Oncology, 2022, 148 : 1709 - 1709
  • [25] Durable Responses in Patients With Advanced Cholangiocarcinoma on Sequential Dual-agent Immunotherapy After Progressing on Single-agent Immunotherapy
    Kaakour, Dalia
    Hagopian, Garo
    Lee, Sonia
    Lee, Fa Chyi
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (10): : 410 - 414
  • [26] Single-agent gemcitabine versus cisplatin/etoposide in patients with inoperable, locally advanced, or metastatic non-small cell lung cancer
    Manegold, C
    [J]. SEMINARS IN ONCOLOGY, 1998, 25 (04) : 18 - 22
  • [27] Capecitabine (X) as single agent in elderly patients (p) with metastatic breast cancer (MBC).
    Zamora, P
    de Mon, MA
    Calvo, L
    Jara, C
    Virizuela, JA
    Yubero, A
    Chacón, JI
    Mira, J
    Barón, MG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 88S - 88S
  • [28] Gemcitabine as single-agent therapy in the management of advanced breast cancer
    Seidman, AD
    [J]. ONCOLOGY-NEW YORK, 2001, 15 (02): : 11 - 14
  • [29] The retrospective study of single-agent capecitabine in the maintenance treatment of recurrent and metastatic breast cancer.
    Huang, H.
    Jiang, Z.
    Wang, T.
    Zhang, S.
    Bian, L.
    Cao, Y.
    Wu, S.
    Song, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] Fatigue in patients with locally advanced or metastatic breast cancer undergoing single-agent taxane-based chemotherapy: de novo versus relapsed
    Blaes, Anne
    Gavioli, Elizabeth M.
    Wakade, Renuka
    Miracle, Santiago
    DiTuri, Giovanna
    DePizzol, Maria
    Ruffini, Pier Adelchi
    Sergio, Francesco
    Leone, Manuela
    Mantelli, Flavio
    Allegretti, Marcello
    Fabi, Alessandra
    [J]. CANCER RESEARCH, 2023, 83 (05)
12345